128 related articles for article (PubMed ID: 86358)
1. Estrogens in carcinoma of the prostate. Effects on enzymes and polypeptide hormones.
Dunzendorfer U; Drahovsky D
Arzneimittelforschung; 1978; 28(6):1027-30. PubMed ID: 86358
[TBL] [Abstract][Full Text] [Related]
2. Altered polyamines and peptide hormones (FSH, TSH, prolactin, C-peptide) in prostatic hyperplasia and kidney tumors.
Dunzendorfer U; Russell DH
Cell Mol Biol Incl Cyto Enzymol; 1979; 24(4):301-5. PubMed ID: 91441
[No Abstract] [Full Text] [Related]
3. [Clinical significance of peptide hormones LH, FSH, TSH, prolactin, HCG, parathormone, calcitonin and prostaglandin F2 alpha in kidney neoplasms].
Dunzendorfer U; Drahovsky D; Schmidt-Gayk H; Zahradnik HP
Z Urol Nephrol; 1981 Jan; 74(1):13-9. PubMed ID: 6785940
[TBL] [Abstract][Full Text] [Related]
4. Testosterone levels in benign prostatic hypertrophy and prostate cancer.
Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M
Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481
[TBL] [Abstract][Full Text] [Related]
5. FSH and LH elevation after radiation for treatment of cancer of the prostate.
Seal US
Invest Urol; 1979 Jan; 16(4):278-80. PubMed ID: 429120
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
7. [Testosterone, FSH and LH level in the serum of patients with prostatic neoplasms, treated with female hormones].
Weidner W; Krause W; Pust R; Engstfeld J; Rothauge CF
Helv Chir Acta; 1978 Jul; 45(3):287-90. PubMed ID: 701064
[TBL] [Abstract][Full Text] [Related]
8. [Peptide hormones LH, FSH, TSH, prolactin, beta-HCG and PTH in patients with urogenital tumors].
Dunzendorfer U; Drahovsky D; Schmidt-Gayk H
Onkologie; 1981 Aug; 4(4):188-92. PubMed ID: 6795555
[TBL] [Abstract][Full Text] [Related]
9. [Interdependence between hormonal disorders, staging and degree of malignancy of prostatic gland cancer. 2].
Szymanowski J; Baranowska B; Rozbicka G; Jeske W; Zgliczynski S
J Urol (Paris); 1983; 89(9):663-8. PubMed ID: 6425418
[TBL] [Abstract][Full Text] [Related]
10. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
Bartsch G; Oberholzer M; Rohr HP
Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105
[TBL] [Abstract][Full Text] [Related]
11. [Bromocryptin, a new therapeutic principle in adenoma and carcinoma of the prostate. Presuppositions, possibilities and limitations].
Jacobi GH; Altwein JE
Minerva Urol; 1980; 32(3):167-73. PubMed ID: 6159524
[No Abstract] [Full Text] [Related]
12. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
Katayama T; Umeda K; Kazama T
Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
[TBL] [Abstract][Full Text] [Related]
13. Leucine aminopeptidase activity in benign hyperplastic and malignant prostatic tissue.
Udeh FN
Invest Urol; 1966 Jan; 3(4):413-8. PubMed ID: 4160243
[No Abstract] [Full Text] [Related]
14. Serum hormones in human breast cancer subjects.
Krishnamoorthy G; Govindarajulu P; Ramalingam V
Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
[TBL] [Abstract][Full Text] [Related]
15. [Histochemical characteristics of the prostate gland under normal conditions, in nodular hyperplasia and cancer].
Bialik VV
Arkh Patol; 1973; 35(12):12-8. PubMed ID: 4130950
[No Abstract] [Full Text] [Related]
16. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal changes in carcinoma of the prostate].
Rodrigues-Netto Júnior N; Da Silva RP; Hernández AJ
Rev Paul Med; 1979; 94(1-2):24-6. PubMed ID: 120973
[No Abstract] [Full Text] [Related]
18. Hormonal modulation of biosynthesis of prostatic specific antigen, prostate specific acid phosphatase and prostatic inhibin peptide.
Sheth AR; Garde SV; Mehta MK; Shah MG
Indian J Exp Biol; 1992 Mar; 30(3):157-61. PubMed ID: 1380948
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic responses of transplanted tumour cells towards estrogen, progesterone and testosterone.
Das S; Roychowdhury J; Banerjee S
Endocrinol Jpn; 1976 Aug; 23(4):275-9. PubMed ID: 139308
[TBL] [Abstract][Full Text] [Related]
20. [Diurnal variation of the elevated acid phosphatase activity in cases of prostate carcinoma (author's transl)].
Wisser H; Knoll E; Schmid G
J Clin Chem Clin Biochem; 1980 May; 18(5):297-301. PubMed ID: 7191887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
